Indaptus Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Indaptus Therapeutics, Inc. (INDP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.09 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2022-08-08
- Indaptus Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-06-30 was 3.09M shares.
- Indaptus Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 3.09M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month |
|---|---|
| 2022-06-30 | 3.09M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 3.09M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |